We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$36.4B
AUM Growth
+$3.53B
Cap. Flow
+$1.12B
Cap. Flow %
3.08%
Top 10 Hldgs %
20.83%
Holding
3,908
New
299
Increased
2,042
Reduced
1,302
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Financials 4.99%
3 Consumer Discretionary 3.69%
4 Communication Services 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWPX icon
3026
NWPX Infrastructure Inc
NWPX
$1.11B
$332K ﹤0.01%
6,273
VKTX icon
3027
Viking Therapeutics
VKTX
$3.84B
$332K ﹤0.01%
12,616
-950
-7% -$28.3K
WOR icon
3028
Worthington Enterprises
WOR
$2.85B
$332K ﹤0.01%
5,991
-483
-7% -$30.4K
FCNCA icon
3029
First Citizens BancShares
FCNCA
$25.6B
$331K ﹤0.01%
185
-20
-10% -$39.4K
UTI icon
3030
Universal Technical Institute
UTI
$1.42B
$331K ﹤0.01%
10,158
+4,041
+66% +$119K
UTWO icon
3031
US Treasury 2 Year Note ETF
UTWO
$490M
$331K ﹤0.01%
6,815
-104
-2% -$5.04K
WHF icon
3032
WhiteHorse Finance
WHF
$152M
$331K ﹤0.01%
47,861
+624
+1% +$5.34K
AUGM
3033
FT Vest U.S. Equity Max Buffer ETF - August
AUGM
$31.8M
$331K ﹤0.01%
9,846
+2,138
+28% +$71.2K
HURN icon
3034
Huron Consulting
HURN
$2.47B
$330K ﹤0.01%
2,247
+33
+1% +$4.5K
TGTX icon
3035
TG Therapeutics
TGTX
$7.34B
$330K ﹤0.01%
+9,133
New +$301K
VRNA
3036
DELISTED
Verona Pharma
VRNA
$330K ﹤0.01%
3,091
-951
-24% -$99.3K
IMAR icon
3037
Innovator International Developed Power Buffer ETF March
IMAR
$111M
$329K ﹤0.01%
11,349
-200
-2% -$5.7K
TDOC icon
3038
Teladoc Health
TDOC
$1.26B
$328K ﹤0.01%
42,390
+20,525
+94% +$160K
XSW icon
3039
State Street SPDR S&P Software & Services ETF
XSW
$515M
$328K ﹤0.01%
1,660
-641
-28% -$122K
CGGG
3040
Capital Group U.S. Large Growth ETF
CGGG
$73.1M
$328K ﹤0.01%
+11,525
New +$318K
KOKU icon
3041
Xtrackers MSCI Kokusai Equity ETF
KOKU
$822M
$327K ﹤0.01%
2,800
ULS icon
3042
UL Solutions
ULS
$15.5B
$327K ﹤0.01%
4,620
-10
-0.2% -$682
LST
3043
Leuthold Select Industries ETF
LST
$170M
$327K ﹤0.01%
+8,190
New +$309K
BBN icon
3044
BlackRock Taxable Municipal Bond Trust
BBN
$987M
$326K ﹤0.01%
19,642
-49,002
-71% -$795K
BKLC icon
3045
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.72B
$326K ﹤0.01%
7,617
+606
+9% +$24.9K
CCNE icon
3046
CNB Financial Corp
CCNE
$1.04B
$326K ﹤0.01%
+13,476
New +$333K
EEMA icon
3047
iShares MSCI Emerging Markets Asia ETF
EEMA
$871M
$326K ﹤0.01%
+3,552
New +$307K
NOG icon
3048
Northern Oil and Gas
NOG
$2.61B
$326K ﹤0.01%
13,164
-83
-0.6% -$2.2K
NWBI icon
3049
Northwest Bancshares
NWBI
$2.31B
$326K ﹤0.01%
26,315
+3,213
+14% +$40.4K
CCK icon
3050
Crown Holdings
CCK
$12.9B
$325K ﹤0.01%
3,363
+163
+5% +$16.4K

Similar funds

Cambridge Investment Research Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Cambridge Investment Research Advisors held 3,908 positions worth $36.4B, up 11% from $32.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $1.12B of net new capital in Q3 2025, opening 299 new positions and adding to 2,042 existing holdings. Its largest new stake was Scharf ETF: 195,274 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $27.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2025 buy was Scharf ETF: 195,274 shares worth $11M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $67.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $27.2M.
  • Cambridge Investment Research Advisors fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $8.43M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $36.4B portfolio in Q3 2025.
  • Cambridge Investment Research Advisors opened 299 new positions and closed 193 in Q3 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $36.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.